Risultati della ricerca - David Nemirovsky

Virtual Biostats Day: An Interactive Online Biostatistics Outreach Program Directed at High School Students in Groups Historically Underrepresented in STEM Careers di Esther Drill, Jessica A. Lavery, Stephanie Lobaugh, Jessica Flynn, Samantha Brown, Hannah Kalvin, Joanne F. Chou, David Nemirovsky, Zoe Guan, Sujata Patil, Kay See Tan

Testo

Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction di Meira Yisraeli Salman, Alexander R. Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Yannis K. Valtis, Leora Boussi, Theresa Spivey, Wenbin Xiao, Christopher Famulare, Jenna Ciervo, Jacob M. Rowe, Martin S. Tallman, Eytan M. Stein

Testo

Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma di Tara Sebastian, Sridevi Rajeeve, Tasmin Farzana, Ross Firestone, Eric Jurgens, Kevin Miller, Bruno Almeida Costa, Alexander Lesokhin, Carlyn Rose Tan, Gunjan Shah, Neha Korde, Heather Landau, Michael Scordo, Hani Hassoun, Kylee Maclachlan, Urvi Shah, Malin Hultcrantz, Andriy Derkach, David Nemirovsky, Sergio Giralt, Saad Usmani, Sham Mailankody, Hamza Hashmi

Testo

Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma di Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi Shah, Kylee Maclachlan, Dhwani Patel, Oscar B. Lahoud, Heather J. Landau, David J. Chung, Gunjan L. Shah, Michael Scordo, Sergio A. Giralt, Alexander Lesokhin, Saad Z. Usmani, Ola Landgren, Neha Korde

Testo

Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma di Benjamin Adegbite, Carlyn Rose Tan, Tala Shekarkhand, Ross S. Firestone, Eric M. Jurgens, Kevin Miller, Alexander M. Lesokhin, Gunjan L. Shah, Neha Korde, Sridevi Rajeeve, Heather J. Landau, Michael Scordo, Hani Hassoun, Kylee H. Maclachlan, Urvi A. Shah, Malin Hultcrantz, Issam S. Hamadeh, Andriy Derkach, David Nemirovsky, Sergio A. Giralt, Sham Mailankody, Saad Z. Usmani, Hamza Hashmi

Testo

Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing di Carlyn Rose Tan, Alice Wang, David Nemirovsky, Andriy Derkach, Tala Shekarkhand, Issam Hamadeh, Kylee Maclachlan, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Alexander Lesokhin, Urvi A. Shah, Sridevi Rajeeve, Hamza Hashmi, Dhwani Patel, Ross Firestone, Eric Jurgens, Kevin Miller, Gunjan L. Shah, Michael Scordo, Heather J. Landau, Sergio A. Giralt, Neha Korde, Saad Z. Usmani

Testo

Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma di Eric Jurgens, Tala Shekarkhand, Colin Rueda, David Nemirovsky, Andriy Derkach, Ross S. Firestone, Kevin Miller, Bruno Almeida Costa, Sridevi Rajeeve, Alexander M. Lesokhin, Neha Korde, Carlyn R. Tan, Hamza Hashmi, Hani Hassoun, Kylee Maclachlan, Urvi A. Shah, Malin Hultcrantz, Issam Hamadeh, Sergio A. Giralt, Gunjan L. Shah, Heather J. Landau, Michael Scordo, Saad Z. Usmani, Sham Mailankody, Zainab Shahid

Testo

Comparison of infectious complications with BCMA-directed therapies in multiple myeloma di Karthik Nath, Tala Shekarkhand, David Nemirovsky, Andriy Derkach, Bruno Almeida Costa, Noriko Nishimura, Tasmin Farzana, Colin Rueda, David J. Chung, Heather J. Landau, Oscar B. Lahoud, Michael Scordo, Gunjan L. Shah, Hani Hassoun, Kylee Maclachlan, Neha Korde, Urvi A. Shah, Carlyn Rose Tan, Malin Hultcrantz, Sergio A. Giralt, Saad Z. Usmani, Zainab Shahid, Sham Mailankody, Alexander M. Lesokhin

Testo

Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma di Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve, Tasmin Farzana, Ross S. Firestone, Eric M. Jurgens, Kevin C. Miller, Francesco Maura, Alexander M. Lesokhin, Carlyn R. Tan, Gunjan L. Shah, Neha Korde, Heather J. Landau, Maximillian Merz, Michael Scordo, Hani Hassoun, Kylee H. Maclachlan, Urvi A. Shah, Malin L. Hultcrantz, Andriy Derkach, David Nemirovsky, Sergio Giralt, Sham Mailankody, Saad Z. Usmani

Testo

Patterns and safety of glucocorticosteroid use following CD19 CAR‐T therapy for large B‐cell lymphoma di Efrat Luttwak, David Nemirovsky, Sean M. Devlin, Alexander P. Boardman, Giulio Cassanello, Magdalena Corona, Danny Luan, Parastoo B. Dahi, Alejandro Luna De Abia, Lorenzo Falchi, Ivan Landego, Richard J. Lin, Jeniffer K. Lue, Lia M. Palomba, Jae H. Park, Sandeep S. Raj, Kai Rejeski, Alfredo Rivas Delgado, Michael Scordo, Ana Alarcon Tomas, Gunjan L. Shah, Miguel‐Angel Perales, Gilles Salles, Roni Shouval

Testo

Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma di Malin Hultcrantz, Hani Hassoun, Neha Korde, Kylee MacLachlan, Sham Mailankody, Dhwani Patel, Urvi A. Shah, Carlyn Rose Tan, David J. Chung, Oscar B. Lahoud, Heather J. Landau, Michael Scordo, Gunjan L. Shah, Sergio A. Giralt, Matthew J. Pianko, Miranda Burge, Kelly Barnett, Meghan Salcedo, Julia Caple, Linh Tran, Jenna Blaslov, Tala Shekarkhand, Selena Hamid, David Nemirovsky, Andriy Derkach, Oluwatobi Arisa, Cody J. Peer, William D. Figg, Saad Z. Usmani, Ola Landgren, Alexander M. Lesokhin

Testo

Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL di Daniela R. Anderson, Radhika Gangaraju, Wafik George Sedhom, Eva N. Hamulyák, Tzu-Fei Wang, Kristin O'Dwyer, Brian J. Carney, Chandrasekar Muthiah, Michaela Liedtke, Talha Badar, Shai Shimony, Renana Robinson, Kristen Sanfilippo, Andriy Derkach, Shira Dinner, Bart J. Biemond, David Nemirovsky, Leah A. Goldberg, Anjani D. Kapadia, Hannah Levavi, Michal Bar-Natan, Grace Van Hyfte, Karan Bansal, Marc Carrier, Jill Fulcher, Anke M. Gerrits, Mark R. Litzow, Selina Luger, Guru Subramanian Guru Murthy, Marlise Luskin, Ofir Wolach, William Shomali, Jeffrey I. Zwicker, Wendy Stock, Avi Leader

Testo